Search Details

Word: accountably (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

Your report on how U.S. forces helped put down a Taliban prisoner-of-war revolt, "Inside the Battle at Qala-i-Jangi," was riveting [TIME EXCLUSIVE, Dec. 10]. Alex Perry's account of the sounds, the smells, the terror and the tragedy inside the Qala-i-Jangi fortress was brilliant, as was his description of the final moments of the ill-fated CIA interrogation of the prisoners. The photographs and graphics highlighted the incisive reporting. Perry has left the competition in the Afghan dust. PATRICK J. SLOYAN Paeonian Springs...

Author: /time Magazine | Title: Letters: Dec. 31, 2001 | 12/31/2001 | See Source »

...October meeting of his war council, Bush began the way he always does, by calling members into account on previous promises. It was Tommy Franks' turn to be on the spot. The Centcom chief had promised several days earlier that by now special forces would have made it into Afghanistan from Uzbekistan, providing the crucial targeting information necessary to wipe out the Taliban's frontline positions. "Has it happened?" Bush asked. Franks did not have the right answer. The weather had been poor, and the U.S. spotters were stranded on the ground in Uzbekistan. The State Department was having difficulty...

Author: /time Magazine | Title: Inside The War Room | 12/31/2001 | See Source »

...estimated 5,000 proteins that they could be devised to attack. On average, only 1 in 1,000 molecules that bind to a target makes its way to human trials. Of the survivors, just 1 in 5 reaches the market. If failures are taken into account, pharmaceutical companies on average spend $802 million--and 10 to 15 years--to develop each new drug, according to a report released on Nov. 30 by the Tufts Center for the Study of Drug Development in Boston...

Author: /time Magazine | Title: Biotech Grows Up | 12/24/2001 | See Source »

This does not bode well for the pharmaceutical industry--nor for patients waiting for a miracle drug. Large pharmaceutical firms such as GlaxoSmithKline and Aventis will each have to launch up to 45 new drugs--not the variations on existing ones that now account for so much of the industry's output (and advertising)--in the next decade if their sales are to grow at an 8% rate, estimates the consultancy Accenture. By 2010 that will mean producing six new drugs a year. Most companies today grind out just one or two a year. "Productivity is the No. 1 issue...

Author: /time Magazine | Title: Biotech Grows Up | 12/24/2001 | See Source »

...Manhattan brasserie Les Halles, where he is now executive chef, which means he shows up with a six-pack of Corona a few times a month and hangs out with the staff. He says he will never cook again; his knees are too shot and his bank account too fat. "I was always more in love with the lifestyle and my cooks than the customer. I didn't have the drive to perfection or the natural ability," he says as he finishes off a second glass of cold sake...

Author: /time Magazine | Title: The Renegade Gourmet | 12/24/2001 | See Source »

Previous | 824 | 825 | 826 | 827 | 828 | 829 | 830 | 831 | 832 | 833 | 834 | 835 | 836 | 837 | 838 | 839 | 840 | 841 | 842 | 843 | 844 | Next